FDAnews Device Daily Bulletin

MALVERN FIRM EXPANDING CAPABILITIES

June 5, 2006
A A

Fujirebio Diagnostics said it acquired 100 percent of the stock and equity of CanAg Diagnostics AB, a Swedish biotechnology company based in Gothenburg, Sweden. Takeo Hayashi, Fujirebio chairman and chief executive, said the acquisition will expand the company's capabilities in cancer diagnostics and give Fujirebio a bigger worldwide presence. Financial terms were not disclosed.
Daily Local News Online